Evaluating Human Papillomavirus Vaccine Safety and Effectiveness in an Integrated Healthcare Delivery System

January 25, 2019

Allison Naleway, Ph.D. gives an overview of the research programs at the Kaiser Permanente Center for Health Research, discusses the unique data and specimen resources they have, and provides details and examples from her studies of HPV vaccine safety and effectiveness.

Allison Naleway, Ph.D., is an epidemiologist whose research focuses on the evaluation of vaccine safety and effectiveness and the surveillance of vaccine-preventable and other infectious diseases. She is a Distinguished Investigator and Associate Director of Science Programs at the Kaiser Permanente Center of Health Research, Portland Oregon.

Allison serves as the site Principal Investigator for the Vaccine Safety Datalink (VDS), a national project funded by the Centers for Disease Control and Prevention (CDC) that links automated medical records data from several integrated health care delivery organizations to monitor vaccine safety. She leads the VSD pregnancy working group.

She has collaborated with the CDC on studies to assess the effectiveness of influenza vaccination during pregnancy, influenza vaccine choice and effectiveness in health care workers, and the early effect of human papillomavirus vaccination on HPV-related outcomes.